Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

SUBCUTANEOUS AND INTRADERMAL VACCINATION WITH ASIAN INFLUENZA VACCINE

SUBCUTANEOUS AND INTRADERMAL VACCINATION WITH ASIAN INFLUENZA VACCINE Since the isolation of the Asian influenza virus in May, 1957,1 there has been a tremendous marshalling of public health services, research and laboratory teams, and production facilities. Further, as one of the phenomena of our times, we have seen in the lay press immediate and broad coverage of all aspects of an anticipated influenza epidemic, of vaccine production and distribution difficulties, and of the uncertainties of dosage schedules and efficacy of the vaccine. As is natural, an enlightened public has sought immunization at a time when supplies of the vaccine are insufficient to meet the demand and, indeed, at a time when the physician has only the most general statements for guidance in his immunization procedures. Under these circumstances it is understandable that, with previous experience with influenza vaccine of the ordinary type as precedent,2 attempts have been made to stretch the limited supply of the Asian http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

SUBCUTANEOUS AND INTRADERMAL VACCINATION WITH ASIAN INFLUENZA VACCINE

JAMA , Volume 165 (13) – Nov 30, 1957

Loading next page...
 
/lp/american-medical-association/subcutaneous-and-intradermal-vaccination-with-asian-influenza-vaccine-XbIYq5FjNv

References (2)

Publisher
American Medical Association
Copyright
Copyright © 1957 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1957.72980310001010
Publisher site
See Article on Publisher Site

Abstract

Since the isolation of the Asian influenza virus in May, 1957,1 there has been a tremendous marshalling of public health services, research and laboratory teams, and production facilities. Further, as one of the phenomena of our times, we have seen in the lay press immediate and broad coverage of all aspects of an anticipated influenza epidemic, of vaccine production and distribution difficulties, and of the uncertainties of dosage schedules and efficacy of the vaccine. As is natural, an enlightened public has sought immunization at a time when supplies of the vaccine are insufficient to meet the demand and, indeed, at a time when the physician has only the most general statements for guidance in his immunization procedures. Under these circumstances it is understandable that, with previous experience with influenza vaccine of the ordinary type as precedent,2 attempts have been made to stretch the limited supply of the Asian

Journal

JAMAAmerican Medical Association

Published: Nov 30, 1957

There are no references for this article.